The Europe Virtual Clinical Trials Market would witness market growth of 7.3% CAGR during the forecast period (2020-2026). Another name for virtual trials is decentralized trials. Virtual trials have a major role to play in the current COVID-19 pandemic and are likely to be a rule in the ways trials and real-world research are run. A virtual technique permits people to participate in the trial from the comfort of their homes which ensures that studies can be continued even when site visits are not feasible. Furthermore, it is a unique method of gathering secure and effective data from participants of clinical researches.
Recently, a rise in the complexity and volume of clinical trials has been observed, which have a significant role to play in the R&D of new drugs and other items. Besides, the cost of clinical trials has been increasing, contributing to the overall cost of creating a drug. Therefore, large pharmaceuticals and small biotechnology companies are searching for innovative methods to enhance trial results and reduce the costs of the trial.
Monitoring of remote patients and virtual visits to physical site visits provide members a choice and comfort of not prone to unnecessary dangers. The virtual examination empowers sponsors to include a bigger population in the research, hence enhancing recruitment, engagement, and retention. Besides, it allows continuous and real-time collection of data with the help of digital health technologies. Finally, virtual connectivity, management, and monitoring can majorly reduce the effort, participants’ burden and time commitments, CRCs, and investigators.
Based on Study Type, the market is segmented into Interventional, Observational, and Expanded Access and Others. Based on Indication, the market is segmented into Oncology, Cardiovascular, Immunology, Gastrointestinal, Respiratory, Endocrinology, Ophthalmology and Other Indications. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: Virtual Clinical Trials Market in Europe is expected to register a CAGR of 7.3% during the forecast period (2020-2026)
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include IQVIA Holdings, Inc., ICON PLC, Laboratory Corporation of America Holdings (Covance, Inc.), Dassault Systemes SE (Medidata Solutions, Inc.), Oracle Corporation, Parexel International Corporation (Pamplona Capital Management), PRA Health Sciences, Inc. (KKR & Co., Inc.), Medpace Holdings, Inc., Medable, Inc. and Clinical Ink, Inc. (G.I. Partners)
Scope of the Study
Market Segments Covered in the Report:
By Study Type
- Interventional
- Observational
- Expanded Access
- Others
By Indication
- Oncology
- Cardiovascular
- Immunology
- Gastrointestinal
- Respiratory
- Endocrinology
- Ophthalmology
- Other Indications
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- IQVIA Holdings, Inc.
- ICON PLC
- Laboratory Corporation of America Holdings (Covance, Inc.)
- Dassault Systemes SE (Medidata Solutions, Inc.)
- Oracle Corporation
- Parexel International Corporation (Pamplona Capital Management)
- PRA Health Sciences, Inc. (KKR & Co., Inc.)
- Medpace Holdings, Inc.
- Medable, Inc.
- Clinical Ink, Inc. (G.I. Partners)
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Virtual Clinical Trials Market, by Study Type
1.4.2 Europe Virtual Clinical Trials Market, by Indication
1.4.3 Europe Virtual Clinical Trials Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Geographical Expansions
3.2.4 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Oct – 2020, Nov) Leading Players
3.3.3 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2020, Oct) Leading Players
Chapter 4. Europe Virtual Clinical Trials Market by Study Type
4.1 Europe Interventional Market by Country
4.2 Europe Observational Market by Country
4.3 Europe Expanded Access Market by Country
Chapter 5. Europe Virtual Clinical Trials Market by Indication
5.1 Europe Oncology Market by Country
5.2 Europe Cardiovascular Market by Country
5.3 Europe Immunology Market by Country
5.4 Europe Gastrointestinal Market by Country
5.5 Europe Respiratory Market by Country
5.6 Europe Endocrinology Market by Country
5.7 Europe Ophthalmology Market by Country
5.8 Europe Other Indications Market by Country
Chapter 6. Europe Virtual Clinical Trials Market by Country
6.1 Germany Virtual Clinical Trials Market
6.1.1 Germany Virtual Clinical Trials Market by Study Type
6.1.2 Germany Virtual Clinical Trials Market by Indication
6.2 UK Virtual Clinical Trials Market
6.2.1 UK Virtual Clinical Trials Market by Study Type
6.2.2 UK Virtual Clinical Trials Market by Indication
6.3 France Virtual Clinical Trials Market
6.3.1 France Virtual Clinical Trials Market by Study Type
6.3.2 France Virtual Clinical Trials Market by Indication
6.4 Russia Virtual Clinical Trials Market
6.4.1 Russia Virtual Clinical Trials Market by Study Type
6.4.2 Russia Virtual Clinical Trials Market by Indication
6.5 Spain Virtual Clinical Trials Market
6.5.1 Spain Virtual Clinical Trials Market by Study Type
6.5.2 Spain Virtual Clinical Trials Market by Indication
6.6 Italy Virtual Clinical Trials Market
6.6.1 Italy Virtual Clinical Trials Market by Study Type
6.6.2 Italy Virtual Clinical Trials Market by Indication
6.7 Rest of Europe Virtual Clinical Trials Market
6.7.1 Rest of Europe Virtual Clinical Trials Market by Study Type
6.7.2 Rest of Europe Virtual Clinical Trials Market by Indication
Chapter 7. Company Profiles
7.1 IQVIA Holdings, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Partnerships, Collaborations, and Agreements:
7.1.4.2 Product Launches and Product Expansions:
7.2 ICON PLC
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.1 Recent strategies and developments:
7.2.1.1 Partnerships, Collaborations, and Agreements:
7.2.1.2 Product Launches and Product Expansions:
7.2.1.3 Acquisition and Mergers:
7.3 Laboratory Corporation of America Holdings (Covance, Inc.)
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Recent strategies and developments:
7.3.4.1 Product Launches and Product Expansions:
7.3.4.2 Acquisition and Mergers:
7.4 Dassault Systemes SE (Medidata Solutions, Inc.)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Product Launches and Product Expansions:
7.4.5.3 Acquisition and Mergers:
7.5 Oracle Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Product Launches and Product Expansions:
7.6 Parexel International Corporation (Pamplona Capital Management)
7.6.1 Company Overview
7.6.2 Recent strategies and developments:
7.6.2.1 Partnerships, Collaborations, and Agreements:
7.6.2.2 Product Launches and Product Expansions:
7.6.2.3 Geographical Expansions:
7.7 PRA Health Sciences, Inc. (KKR & Co., Inc.)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental Analysis
7.7.4 Recent strategies and developments:
7.7.4.1 Partnerships, Collaborations, and Agreements:
7.7.4.2 Product Launches and Product Expansions:
7.8 Medpace Holdings, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Recent strategies and developments:
7.8.3.1 Partnerships, Collaborations, and Agreements:
7.9 Medable, Inc.
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Partnerships, Collaborations, and Agreements:
7.9.2.2 Product Launches and Product Expansions:
7.10. Clinical Ink, Inc. (G.I. Partners)
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
TABLE 1 Europe Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 2 Europe Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Virtual Clinical Trials Market
TABLE 4 Product Launches And Product Expansions– Virtual Clinical Trials Market
TABLE 5 Geographical Expansions – Virtual Clinical Trials Market
TABLE 6 Acquisition and Mergers– Virtual Clinical Trials Market
TABLE 7 Europe Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 8 Europe Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 9 Europe Interventional Market by Country, 2016 - 2019, USD Million
TABLE 10 Europe Interventional Market by Country, 2020 - 2026, USD Million
TABLE 11 Europe Observational Market by Country, 2016 - 2019, USD Million
TABLE 12 Europe Observational Market by Country, 2020 - 2026, USD Million
TABLE 13 Europe Expanded Access Market by Country, 2016 - 2019, USD Million
TABLE 14 Europe Expanded Access Market by Country, 2020 - 2026, USD Million
TABLE 15 Europe Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 16 Europe Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 17 Europe Oncology Market by Country, 2016 - 2019, USD Million
TABLE 18 Europe Oncology Market by Country, 2020 - 2026, USD Million
TABLE 19 Europe Cardiovascular Market by Country, 2016 - 2019, USD Million
TABLE 20 Europe Cardiovascular Market by Country, 2020 - 2026, USD Million
TABLE 21 Europe Immunology Market by Country, 2016 - 2019, USD Million
TABLE 22 Europe Immunology Market by Country, 2020 - 2026, USD Million
TABLE 23 Europe Gastrointestinal Market by Country, 2016 - 2019, USD Million
TABLE 24 Europe Gastrointestinal Market by Country, 2020 - 2026, USD Million
TABLE 25 Europe Respiratory Market by Country, 2016 - 2019, USD Million
TABLE 26 Europe Respiratory Market by Country, 2020 - 2026, USD Million
TABLE 27 Europe Endocrinology Market by Country, 2016 - 2019, USD Million
TABLE 28 Europe Endocrinology Market by Country, 2020 - 2026, USD Million
TABLE 29 Europe Ophthalmology Market by Country, 2016 - 2019, USD Million
TABLE 30 Europe Ophthalmology Market by Country, 2020 - 2026, USD Million
TABLE 31 Europe Other Indications Market by Country, 2016 - 2019, USD Million
TABLE 32 Europe Other Indications Market by Country, 2020 - 2026, USD Million
TABLE 33 Europe Virtual Clinical Trials Market by Country, 2016 - 2019, USD Million
TABLE 34 Europe Virtual Clinical Trials Market by Country, 2020 - 2026, USD Million
TABLE 35 Germany Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 36 Germany Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 37 Germany Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 38 Germany Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 39 Germany Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 40 Germany Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 41 UK Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 42 UK Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 43 UK Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 44 UK Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 45 UK Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 46 UK Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 47 France Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 48 France Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 49 France Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 50 France Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 51 France Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 52 France Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 53 Russia Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 54 Russia Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 55 Russia Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 56 Russia Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 57 Russia Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 58 Russia Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 59 Spain Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 60 Spain Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 61 Spain Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 62 Spain Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 63 Spain Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 64 Spain Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 65 Italy Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 66 Italy Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 67 Italy Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 68 Italy Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 69 Italy Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 70 Italy Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 71 Rest of Europe Virtual Clinical Trials Market, 2016 - 2019, USD Million
TABLE 72 Rest of Europe Virtual Clinical Trials Market, 2020 - 2026, USD Million
TABLE 73 Rest of Europe Virtual Clinical Trials Market by Study Type, 2016 - 2019, USD Million
TABLE 74 Rest of Europe Virtual Clinical Trials Market by Study Type, 2020 - 2026, USD Million
TABLE 75 Rest of Europe Virtual Clinical Trials Market by Indication, 2016 - 2019, USD Million
TABLE 76 Rest of Europe Virtual Clinical Trials Market by Indication, 2020 - 2026, USD Million
TABLE 77 Key information – IQVIA Holdings, Inc.
TABLE 78 Key Information – ICON PLC
TABLE 79 Key Information – Laboratory Corporation of America holdings
TABLE 80 Key Information – Dassault Systemes SE
TABLE 81 Key Information – Oracle Corporation
TABLE 82 Key Information – PAREXEL International Corporation
TABLE 83 Key Information – PRA Health Sciences, Inc.
TABLE 84 key Information – Medpace Holdings, Inc.
TABLE 85 Key Information – Medable, Inc.
TABLE 86 Key Information – Clinical Ink, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2016-2020)
FIG 4 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2017, Feb – 2020, Dec) Leading Players
FIG 5 Key Strategic Move: (Product Launches and Product Expansions : 2018, Jun – 2020, Oct) Leading Players
FIG 6 Recent strategies and developments: IQVIA Holdings, Inc.
FIG 7 Recent strategies and developments: ICON PLC
FIG 8 Recent strategies and developments: Laboratory Corporation of America
FIG 9 Recent strategies and developments: Dassault Systemes SE
FIG 10 Recent strategies and developments: Oracle Corporation
FIG 11 Recent strategies and developments: Parexel International Corporation
FIG 12 Recent strategies and developments: PRA Health Sciences, Inc.
FIG 13 Recent strategies and developments: Medable, Inc.